PPARG and chronic pancreatitis: Thiazolidinediones, antidiabetic drugs, and synthetic ligands of peroxisome proliferator-activated receptor gamma (PPARγ) have been shown to inhibit the activation of PSC in vitro [6], and in animal models, PPARgamma ligands have been shown to ameliorate the development of chronic pancreatitis [7, 8].